<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Vestnik dermatologii i venerologii</journal-id><journal-title-group><journal-title xml:lang="en">Vestnik dermatologii i venerologii</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник дерматологии и венерологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0042-4609</issn><issn publication-format="electronic">2313-6294</issn><publisher><publisher-name xml:lang="en">Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">101</article-id><article-id pub-id-type="doi">10.25208/0042-4609-2015-91-1-24-31</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>EDITORIAL</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Редакционная статья</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Photodynamic therapy for mycosis fungoides: a case series and review of the literature</article-title><trans-title-group xml:lang="ru"><trans-title>Фотодинамическая терапия грибовидного микоза: исследование серии случаев и обзор литературы</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hunger</surname><given-names>Robert E.</given-names></name><address><country country="RU">Russian Federation</country></address><email>robert.hunger@insel.ch</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Sallam</surname><given-names>Mohamed</given-names></name><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Yawalkar</surname><given-names>Nikhil</given-names></name><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">University of Bern</institution></aff><aff><institution xml:lang="ru">Бернский университет</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2015-02-24" publication-format="electronic"><day>24</day><month>02</month><year>2015</year></pub-date><volume>91</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>24</fpage><lpage>31</lpage><history><date date-type="received" iso-8601-date="2017-08-24"><day>24</day><month>08</month><year>2017</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2015, Hunger R.E., Sallam M., Yawalkar N.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2015, Hunger R.E., Sallam M., Yawalkar N.</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="en">Hunger R.E., Sallam M., Yawalkar N.</copyright-holder><copyright-holder xml:lang="ru">Hunger R.E., Sallam M., Yawalkar N.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikdv.ru/jour/article/view/101">https://vestnikdv.ru/jour/article/view/101</self-uri><abstract xml:lang="en"><p>Mycosis fungoides (MF) is the most common form of cutaneous T cell lymphoma. In early stages of the disease, topical therapeutic approaches like steroids, chemotherapy, phototherapy or spot radiation therapy are most commonly used. Photodynamic therapy (PDT) is widely executed in the treatment of actinic keratosis and superficial basal cell carcinoma. The effective use of PDT for early forms of MF has been previously demonstrated in a series of cases. In this instance, the treatment of MF (n = 6, 11 lesions) with methyl alanine PDT (MAL-PDT) in 73% of the treated lesions showed a complete response. Within the timeframe of 25-51 months, no recurrence of the successfully treated lesions was observed, on the contrary some of the patients developed new lesions on different sites. Hence, this case study shows that patients having a single or few MF lesions can be successfully treated by PDT.</p></abstract><trans-abstract xml:lang="ru"><p>Грибовидный микоз (ГМ) является наиболее распространенной формой Т-клеточной лимфомы кожи. На ранних стадиях заболевания чаще всего используется местная терапия, например стероиды, химиотерапия, фототерапия или точечная лучевая терапия. Фотодинамическая терапия (ФДТ) находит широкое применение при лечении актинического кератоза и поверхностной базальноклеточной карциномы. Эффективность использования ФДТ для ранних форм ГМ была ранее показана в ряде случаев. В данном случае лечение ГМ (n = 6, 11 очагов) при помощи ФДТ с метилаланином (МАЛ-ФДТ) обеспечило полную ответную реакцию для 73% обработанных очагов. На протяжении периода продолжительностью 25-51 мес. не было никаких рецидивов в связи с успешно вылеченными очагами, однако у некоторых пациентов появились новые очаги на различных участках. По результатам данного клинического наблюдения было показано, что пациентов с одним очагом ГМ или небольшим числом очагов ГМ можно успешно лечить при помощи ФДТ.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>photodynamic therapy</kwd><kwd>5-aminolevulinic acid</kwd><kwd>methyl aminolevulinate</kwd><kwd>фотодинамическая терапия</kwd><kwd>5-аминолавулиновая кислота</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Willemze R., Jaffe E.S., Burg G., Cerroni L., Berti E., Swerdlow S.H. et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768-85. Epub 2005/02/05.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Jawed S.I., Myskowski P.L., Horwitz S., Moskowitz A., Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. Journal of the American Academy of Dermatology. 2014; 70(2): 205 e1-16; quiz 2І-2. Epub 2014/01/21.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Jawed S.I., Myskowski P.L., Horwitz S., Moskowitz A., Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part II. Prognosis, management, and future directions. Journal of the American Academy of Dermatology. 2014; 70(2): 223 e1-17; quiz 40-2. Epub 2014/01/21.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Willemze R., Dreyling M. Primary cutaneous lymphomas: ESmO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2010;21 Suppl 5:v177-80. Epub 2010/06/29.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Braathen L.R., Szeimies R.M., Basset-Seguin N., Bissonnette R., Foley P., Pariser D. et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. Journal of the American Academy of Dermatology. 2007;56(1):125-43. Epub 2006/12/28.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Wennberg A.M. Pain, pain relief and other practical issues in photodynamic therapy. The Australasian journal of dermatology. 2005; 46 Suppl 3:S3-4; discussion S23-5. Epub 2005/04/30.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Warren C.B., Karai L.J., Vidimos A., Maytin E.V. Pain associated with aminolevulinic acid-photodynamic therapy of skin disease. Journal of the American Academy of Dermatology. 2009;61(6):1033-43. Epub 2009/11/21.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Wolf P., Fink-Puches R., Cerroni L., Kerl H. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. Journal of the American Academy of Dermatology. 1994;31(4):678-80. Epub 1994/10/01.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Edstrom D.W., Porwit A., Ros A.M. Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: clinical and histological response. Acta dermato-venereologica. 2001; 81(3): 184-8. Epub 2001/09/18.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Edstrom D.W., Hedblad M.A. Long-term follow-up of photodynamic therapy for mycosis fungoides. Acta dermato-venereologica. 2008; 88(3): 288-90. Epub 2008/05/16.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Zane C., Venturini M., Sala R., Calzavara-Pinton P. Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma. Photo-dermatology, photoimmunology &amp; photomedicine. 2006; 22(5): 254-8. Epub 2006/09/05.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Kim S.T., Kang D.Y., Kang J.S., Baek J.W., Jeon Y.S., Suh K.S. Photodynamic therapy with methyl-aminolaevulinic acid for mycosis fungoides. Acta dermato-venereologica. 2012; 92(3): 264-8. Epub 2011/12/16.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Quereux G., Brocard A., Saint-Jean M., Peuvrel L., Knol A.C., Allix R. et al. Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: a prospective open study and review of the literature. Journal of the American Academy of Dermatology. 2013; 69(6): 890-7. Epub 2013/09/18.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Rubel D.M., Spelman L., Murrell D.F., See J.A., Hewitt D., Foley P. et al. Daylight PDT with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional PDT in actinic keratosis treatment: a randomised controlled trial. The British journal of dermatology. 2014. Epub 2014/05/28.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Wiegell S.R., Wulf H.C., Szeimies R.M., Basset-Seguin N., Bissonnette R., Gerritsen M.J. et al. Daylight photodynamic therapy for actinic keratosis: an international consensus: International Society for Photodynamic Therapy in Dermatology. Journal of the European Academy of Dermatology and Venereology: JEADV. 2012; 26(6): 673-9. Epub 2012/01/04.</mixed-citation></ref></ref-list></back></article>
